Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial
Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.4 replaces v3.5.3 on the page, indicating a minor administrative update to the entry. No substantive changes to study details or results are evident.SummaryDifference0.0%

- Check27 days agoChange DetectedTaoyuan, Taiwan, 320 has been updated to Taoyuan City, Taiwan, 320. The locality name was updated while preserving the postal code, reflecting an official naming update in the study's location list.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page’s footer revision identifier was updated from **v3.5.2** to **v3.5.3**, indicating a ClinicalTrials.gov page version refresh without changing the study details shown.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0, indicating a system/template update across the page.SummaryDifference0.0%

- Check85 days agoChange DetectedPage revision note updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.